Slingshot members are tracking this event:

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) Recommends Approval for AbbVie's (ABBV) Shorter Regimen of Viekirax + Exviera in HCV-1b Infection

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 27, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Chmp, Viekirax, Exviera